Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms
Ana C. Puhl, Ethan J. Fritch, Thomas R. Lane, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 16

Showing 16 citing articles:

Construction and applications of SARS-CoV-2 pseudoviruses: a mini review
Minghai Chen, Xian‐En Zhang
International Journal of Biological Sciences (2021) Vol. 17, Iss. 6, pp. 1574-1580
Open Access | Times Cited: 91
Friend or Foe? Implication of the autophagy-lysosome pathway in SARS-CoV-2 infection and COVID-19
Weifeng He, Yuan Gao, Jing Zhou, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4690-4703
Open Access | Times Cited: 20
Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritization
J. J. Patten, Patrick T. Keiser, Deisy Morselli-Gysi, et al.
iScience (2022) Vol. 25, Iss. 9, pp. 104925-104925
Open Access | Times Cited: 17
Research Progress on Spike-Dependent SARS CoV-2 Fusion Inhibitors and Small Molecules Targeting the S2 Subunit of Spike
Matthew R. Freidel, Roger S. Armen
(2024)
Open Access | Times Cited: 1
Approaches to evaluate the specific immune responses to SARS-CoV-2
Ana López-Gomez, Hector F. Pelaez-Prestel, Ignacio Juárez
Vaccine (2023) Vol. 41, Iss. 43, pp. 6434-6443
Open Access | Times Cited: 4
Cationic Compounds with SARS-CoV-2 Antiviral Activity and Their Interaction with Organic Cation Transporter/Multidrug and Toxin Extruder Secretory Transporters
Lucy J. Martínez-Guerrero, Xiaohong Zhang, Kimberley M. Zorn, et al.
Journal of Pharmacology and Experimental Therapeutics (2021) Vol. 379, Iss. 1, pp. 96-107
Open Access | Times Cited: 8
Glycyrrhiza glabra L. Extracts and Other Therapeutics against SARS-CoV-2 in Central Eurasia: Available but Overlooked
M. Zh. Zhurinov, A. F. Miftakhova, Viktoriya Keyer, et al.
Molecules (2023) Vol. 28, Iss. 16, pp. 6142-6142
Open Access | Times Cited: 2
Identification of druggable host targets needed for SARS-CoV-2 infection by combined pharmacological evaluation and cellular network directed prioritization both in vitro and in vivo
J. J. Patten, Patrick T. Keiser, Deisy Morselli Gysi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
Repurposing of Drugs Targeted Against COVID-19 Spike Receptor for Treatment: An In silico Approach
Souzia Shaik, S. Ranjani, S. Hemalatha
Biointerface Research in Applied Chemistry (2021) Vol. 11, Iss. 5, pp. 13740-13753
Open Access | Times Cited: 5
Praemonitus praemunitus: can we forecast and prepare for future viral disease outbreaks?
Eugene Muratov
Authorea (Authorea) (2022)
Open Access | Times Cited: 3
Broad-spectrum Respiratory Virus Entry Inhibitors
Hanjun Zhao, Kwok‐Yung Yuen
Advances in experimental medicine and biology (2022), pp. 137-153
Closed Access | Times Cited: 2
Targeting C5aR1 signaling reduced neutrophil extracellular traps and ameliorates COVID-19 pathology
Bruna M. Silva, Flávio P. Veras, Giovanni Freitas Gomes, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Development of Drug Customized Polymeric Carriers for Improved Therapeutic Efficiency
Mohamed M. Abdelghafour
(2023)
Open Access
O papel da sinalização do eixo C5a/C5aR1 na fisiopatologia COVID-19
Bruna Manuella Souza Silva
(2022)
Open Access
Accelerating the Discovery of the Beyond Rule of Five Compounds That Have High Affinities Toward SARS-CoV-2 Spike RBD
Abd Al‐Aziz A. Abu‐Saleh, Arpita Yadav, Raymond A. Poirier
(2021)
Open Access
Accelerating the Discovery of the Beyond Rule of Five Compounds That Have High Affinities Toward SARS-CoV-2 Spike RBD
Abd Al‐Aziz A. Abu‐Saleh, Arpita Yadav, Raymond A. Poirier
(2021)
Open Access
Page 1

Scroll to top